Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02980731
Brief Title: A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent). (VENICE II)

First Submitted : November 30, 2016
First Submitted that Met QC Criteria : November 30, 2016
First Posted : December 2, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 18, 2018
Last Update Posted : December 20, 2018